T3011 not checked

ImmVira Pharma Co. Ltd

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
4 active
7 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“T3011 will be administered at a dose of 1x10\^10 PFU intravesically.”In the company’s words, NCT06971614 on ClinicalTrials.gov
Tested for
Nonmuscle-invasive Bladder Cancer, Solid Tumor, Melanoma, HNSCC, Sarcoma, Squamous Cell Carcinoma, NSCLC, Advanced Melanoma and 1 more
Main trialPhase 2
“This is a Phase II clinical study to evaluate the efficacy and safety of intravesical T3011 injection in participants with BCG-unresponsive high-risk NMIBC or BCG-exposed, chemotherapy-unresponsive intermediate/high-risk NMIBC.”In the company’s words, NCT06971614 on ClinicalTrials.gov

Other drugs for Solid Tumor

All 2440 drugs for Solid Tumor

Coming up2

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials7

TrialPhaseCompletesWhat it tests
Phase 2Recruiting 31 Dec 2028 A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
Phase 1/2Recruiting 22 Sep 2026 A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
Phase 1/2Recruiting 30 Sep 2026 A Clinical Study of T3011 in Subjects With Advanced Melanoma
Phase 1/2Recruiting 31 Dec 2026 A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors
Phase 1/2Unknown Jul 2023 A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors
Phase 1/2Unknown Jun 2024 A Study of T3011 Administered Via Intravenously in Patients With Advanced Solid Tumors.
Phase 1/2Unknown Mar 2025 Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow T3011

Following is part of Solo: you see every change to T3011 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in